News 11 June 2019 Kemal Atlay

Don't forget the 5-ARI factor in prostate testing

Use of 5-alpha reductase inhibitors is associated with delayed diagnosis and higher mortality in men who develop prostate cancer, a study shows.
Specialist Update 06 June 2019 Reuters Health

Older patients 'are being overlooked' for cancer trials

Patients selected to participate in studies of cancer drugs tend to be younger than those with the disease in the general population, according to a US study.
Specialist Update 05 June 2019 Reuters Health

Prostate drug boosts PFS in metastatic disease

In men with metastatic castration-sensitive prostate cancer, adding apalutamide to conventional androgen-deprivation therapy can produce a 52% increase in the rate of radiographic progression-free survival, researchers report.
News 03 June 2019 AAP

Test may predict breast cancer's return

A new blood test that detects genetic changes in tumours could help predict whether women with breast cancer will respond to treatment before it is initiated.
News 28 May 2019 Reuters Health

Lenalidomide may stave off multiple myeloma

Lenalidomide cuts the risk of smouldering multiple myeloma progressing to overt cancer, a randomised controlled phase II/III trial has shown.
Specialist Update 27 May 2019 Clare Pain

Biomarker may 'revolutionise' colorectal cancer management

Personalised circulating tumour DNA could have the potential to be the biomarker routinely used by oncologists treating patients with colorectal cancer, two new studies suggest.
News 24 May 2019 Reuters

Lenalidomide may stave off multiple myeloma

Lenalidomide cuts the risk of smouldering multiple myeloma progressing to overt cancer, a randomised controlled phase II/III trial has shown.
Specialist Update 24 May 2019 Reuters Health

Pembrolizumab fails as monotherapy in breast cancer trial

A phase III trial of pembrolizumab for second- or third-line treatment of metastatic triple-negative breast cancer has failed to demonstrate superior overall survival compared to chemotherapy, manufacturer Merck has announced.
News 21 May 2019 Carmel Sparke

Bowel cancer increasing in younger people

More young people are being diagnosed with bowel cancer in Australia and a number of other high-income countries as rates decline in the over-50s, researchers have found.  
News 20 May 2019 Jocelyn Wright

Call to screen patients with cancer for hepatitis B

All patients about to receive cancer treatment for haematological or solid tumours should be tested for hepatitis B virus (HBV) due to the risk of immunosuppressive treatment reactivating infection, specialists say.